Abstract

  As of January 2020, over 2600 hospitalized cases of e-cigarette, or vaping, product use-associated lung injury (EVALI) have been reported by the US Centers for Disease Control and Prevention. EVALI is a serious public health concern prompting regulatory intervention by the Food and Drug Administration. Published cases have certain common features including neutrophil-predominant leukocytosis and elevated inflammatory markers. Severe cases may require intubation and mechanical ventilation. Hospitalized patients often improve with steroids although regimens published in the literature are highly variable. We report an unusually severe case of EVALI with abnormally elevated inflammatory markers, unusually severe transaminitis and lymphopenia that was nevertheless successfully managed with a relatively conservative regimen of glucocorticoids.

Keywords: EVALI; Lung Injury; Vaping; Vaping Injury; VAPI

References

1. Centers for Disease Control and Prevention. “Outbreak of Lung Injury Associated with the Use of E-Cigarette, or Vaping, Products”. (2020).
2. Food and Drug Administration. “Enforcement Priorities for Electronic Nicotine Delivery System (ENDS) and Other Deemed Products on the Market Without Premarket Authorization”. Guidance for Industry (2020).
3. Butt Y., et al. “Pathology of Vaping-Associated Lung Injury”. New England Journal of Medicine 381.18 (2019): 1780-1781.
4. Layden J., et al. “Pulmonary Illness Related to E-Cigarette Use in Illinois and Wisconsin — Preliminary Report”. New England Journal of Medicine (2019).
5. Centers for Disease Control and Prevention. “Smoking and Tobacco Use”. For Healthcare Providers (2020).
6. Itoh M., et al. “Lung injury associated with electronic cigarettes inhalation diagnosed by transbronchial lung biopsy”. Respirology Case Reports 6.1 (2019).
7. Thota D and Latham E. “Case Report of Electronic Cigarettes Possibly Associated with Eosinophilic Pneumonitis in a Previously Healthy Active-duty Sailor”. The Journal of Emergency Medicine 47.1 (2014): 15-17.
8. Maddock S., et al. “Pulmonary Lipid-Laden Macrophages and Vaping”. New England Journal of Medicine 381.15 (2019): 1488-1489.

Citation

Citation: Frank Womble., et al. “Vaping Associated Lung Injury – An Unusually Severe Case Rapidly Resolved with a Conservative Steroid Regimen”. Acta Scientific Clinical Case Reports 1.2 (2020): 12-13.

Copyright

Copyright: © 2020 Frank Womble., et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.